USPTO serial 79343943
TARGETINGONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- CORDOVA, RAUL
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TARGETINGONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
NAZLY AILEEN BAYRAMOGLU
NAZLY AILEEN BAYRAMOGLU BAYRAMOGLU LAW OFFICES LLC1540 WEST WARM SPRINGS ROADSUITE 100HENDERSON, NV 89014Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; chemical reagents used for rapid extraction of nucleic acids from biological samples; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for detecting and treating infectious diseases, hereditary diseases, leukemia, and cancer; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis; salts for medical purposes; preparations of microorganisms for medical purposes; biological preparations for the treatment of cancer; diagnostic preparations for medical purposes | ACTIVE | — |
| 009 | Measuring apparatus, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; scientific apparatus, namely, polymerase chain reaction (PCR) analyzer for measuring relative DNA, RNA and protein; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; surveying apparatus; surveying instruments; precision measuring apparatus, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; measuring instruments, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; computer software applications, downloadable, for use in medical diagnostic fields; downloadable computer software for application and database integration; diagnostic apparatus for the detection of pathogens for laboratory or research use; medical laboratory research instruments for detecting pathogens and DNA analysis; optical inspection apparatus; sample preparation devices for laboratory or research purposes; scientific apparatus and instruments for extracting, purifying and separating nucleic acid for laboratory or research purposes; technical measuring and testing apparatus and instruments for measuring, testing and checking the temperature, pressure, quantity and concentration of gas and liquids; polymerase chain reaction (PCR) testing apparatus for laboratory or research purpose | ACTIVE | — |
| 010 | Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; sample preparation device for medical diagnostic use; medical apparatus used for rapid extraction, purification and separation of nucleic acid from samples; polymerase chain reaction (PCR) analyzing apparatus for medical purposes; medical diagnostic instruments for the analysis of body fluids; polymerase chain reaction (PCR) testing apparatus for medical purposes; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; blood testing apparatus; inhalers for medical use; insufflators for medical use; cases fitted for medical instruments; surgical apparatus and instruments; probes for medical purposes; medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for detecting cancer; medical diagnostic apparatus for testing cancer cells and DNA, incorporating recorded operating system software | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TargetingOne Corporation
- Other trademarks owned by TargetingOne Corporation
- Other trademarks owned by TargetingOne Corporation
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named TARGETINGONE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 6, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 19, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 19, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 22, 2024 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Nov 22, 2024 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Nov 22, 2024 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Sep 20, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 23, 2024 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Aug 22, 2024 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Aug 22, 2024 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Aug 21, 2024 | OPPF | OPPOSITION PAPERS RECEIVED AT TTAB | — |
| Aug 20, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 12, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2024 | ALIE | ASSIGNED TO LIE | — |
| Jul 3, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 3, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 3, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 22, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Dec 25, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 15, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 6, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 6, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 7, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 23, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 23, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 28, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 5, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 1, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 30, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |